Patents by Inventor Konstanze Konig von Paumbshausen

Konstanze Konig von Paumbshausen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9981920
    Abstract: This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I), (II), (IIa), (III), (IV), (V), or (VI)) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: May 29, 2018
    Assignee: Rodin Therapeutics, Inc.
    Inventors: Martin R. Jefson, Fabian Dey, Konstanze Konig von Paumbshausen, Adrian Schomburg, Andreas Schoop, Russell John Thomas
  • Publication number: 20170204070
    Abstract: This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I), (II), (IIa), (III), (IV), (V), or (VI)) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.
    Type: Application
    Filed: June 25, 2015
    Publication date: July 20, 2017
    Inventors: Martin R. Jefson, Fabian Dey, Konstanze Konig von Paumbshausen, Adrian Schomburg, Andreas Schoop, Russell John Thomas